Intermediate temperature catalytic methane splitting for a swift energy decarbonization
Project ZeroCarb aims to develop an efficient IT-CMS reactor using biomethane and green electricity to produce hydrogen and renewable carbon, facilitating a sustainable energy transition.
Projectdetails
Introduction
Project ZeroCarb will develop, optimize, and operate an intermediate-temperature catalytic methane splitting (IT-CMS) reactor, with the balance of plant, in a relevant environment (TRL6), using biomethane as feedstock and green electricity. This project follows 112CO2 (GA 952219), which developed the fundamentals for the IT-CMS.
Background
It is generally accepted that this reaction, also known as methane decomposition or pyrolysis, will play a critical role in the swift and cost-effective energy transition. Due to this great potential, several different processes have been proposed, and new and existing companies are investing in this technology.
Advantages of IT-CMS Technology
IT-CMS technology displays critical advantages over all other technologies:
- Avoids the use of special reactor envelope materials, since it runs at 750 °C and 1 bar, and is catalytic.
- When fed with biomethane, it produces H2 with a negative CO2 footprint and renewable graphitic carbon.
- The produced metal-free carbon nanofilaments (mostly MWCNT) are shaved off chemically using H2.
- The reactor is more energy efficient since it uses a fixed bed.
- The catalyst is activated steel foil, commercially available, which reduces the CAPEX tremendously.
- The reactor module is expected to display a high power density, approximately 1.5 kW L-1, and energy efficiency > 80 %, with a catalyst high stability > 8500 h.
- Low CAPEX plant, significantly cheaper than an SMR plant.
Project Goals
ZeroCarb targets the development of a demonstration unit producing 2 kg H2 h-1 (approximately 67 kWh2e) and 6 kg C h-1, based on an activated steel foil packed in a plate and frame module.
Market Integration
HyCarb aims to bring this technology into the market and meet industry standards or regulations. The business model will be validated with the two industrial partners:
- CapWatt for hydrogen exploitation (for refineries and synthesis of ammonia/methanol)
- BeDimensional as an off-taker of high-purity carbon (for electrically conductive inks/pastes and electrochemical devices).
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.476.872 |
Totale projectbegroting | € 2.476.872 |
Tijdlijn
Startdatum | 1-4-2025 |
Einddatum | 30-9-2027 |
Subsidiejaar | 2025 |
Partners & Locaties
Projectpartners
- UNIVERSIDADE DO PORTOpenvoerder
- HYCARB Lda
- AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
- CAPWATT METANOL UNIPESSOAL LDA
- BEDIMENSIONAL SPA
Land(en)
Vergelijkbare projecten binnen EIC Transition
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Targeting cardiac fibrosis with next generation RNA therapeuticsFIBREX aims to develop an innovative ncRNA-based antisense oligonucleotide therapy targeting Meg3 to reverse cardiac fibrosis and treat heart failure, advancing towards clinical readiness. | EIC Transition | € 2.499.482 | 2022 | Details |
automated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationSThe NEXUS project aims to industrialize a customizable platform for the separation and analysis of extracellular vesicles from biofluids, enhancing cancer diagnostics and monitoring. | EIC Transition | € 2.497.750 | 2022 | Details |
Predictive REagent-Antibody Replacement Technology stage 2-TranslationPRe-ART-2T aims to advance predictive antibody technology to TRL6, replacing low-quality monoclonal antibodies with high-performing synthetic alternatives, and attract ~€20M in investment. | EIC Transition | € 800.000 | 2022 | Details |
Advancing a vaccine targeting genetic amyotrophic lateral sclerosis (C9orf72 ALS) to the clinical stageDeveloping a poly-GA peptide vaccine to reduce protein aggregation and motor deficits in C9orf72 ALS, aiming for clinical evaluation and market entry through strategic partnerships. | EIC Transition | € 2.499.810 | 2022 | Details |
Targeting cardiac fibrosis with next generation RNA therapeutics
FIBREX aims to develop an innovative ncRNA-based antisense oligonucleotide therapy targeting Meg3 to reverse cardiac fibrosis and treat heart failure, advancing towards clinical readiness.
automated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationS
The NEXUS project aims to industrialize a customizable platform for the separation and analysis of extracellular vesicles from biofluids, enhancing cancer diagnostics and monitoring.
Predictive REagent-Antibody Replacement Technology stage 2-Translation
PRe-ART-2T aims to advance predictive antibody technology to TRL6, replacing low-quality monoclonal antibodies with high-performing synthetic alternatives, and attract ~€20M in investment.
Advancing a vaccine targeting genetic amyotrophic lateral sclerosis (C9orf72 ALS) to the clinical stage
Developing a poly-GA peptide vaccine to reduce protein aggregation and motor deficits in C9orf72 ALS, aiming for clinical evaluation and market entry through strategic partnerships.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Membrane Electrode Assembly for the High Pressure Electrochemical Conversion of CO2 to C2H4The HIPCEO2 project aims to develop a high-pressure electrolyzer prototype using novel Cu-based catalysts for efficient CO2 conversion to ethylene, enhancing selectivity and stability. | ERC POC | € 150.000 | 2022 | Details |
Green H2 and circular bio-coal from biowaste for cost-competitive sustainable SteelH2STEEL aims to transform wet waste into green hydrogen, carbon, and critical raw materials for metallurgy, supporting the EU's net-zero emissions goal through innovative pyrolysis and leaching methods. | EIC Pathfinder | € 2.368.910 | 2022 | Details |
Highly Efficient Reactor for Conversion of CO2 and H2O to Carbon Neutral Fuels and ChemicalsThe project aims to develop a modular reactor technology for synthesizing carbon-neutral fuels and chemicals from CO2 and H2O using renewable energy, promoting sustainability and industrial integration. | EIC Pathfinder | € 2.250.500 | 2023 | Details |
CFC Pilot for CCSThe CFCPILOT4CCS project aims to pilot Carbonate Fuel Cells for CO2 capture from industrial streams in Rotterdam, targeting 46,000 tonnes of greenhouse gas avoidance and enhancing technology for wider application. | InnovFund LSC | € 30.497.000 | 2023 | Details |
Membrane Electrode Assembly for the High Pressure Electrochemical Conversion of CO2 to C2H4
The HIPCEO2 project aims to develop a high-pressure electrolyzer prototype using novel Cu-based catalysts for efficient CO2 conversion to ethylene, enhancing selectivity and stability.
Green H2 and circular bio-coal from biowaste for cost-competitive sustainable Steel
H2STEEL aims to transform wet waste into green hydrogen, carbon, and critical raw materials for metallurgy, supporting the EU's net-zero emissions goal through innovative pyrolysis and leaching methods.
Highly Efficient Reactor for Conversion of CO2 and H2O to Carbon Neutral Fuels and Chemicals
The project aims to develop a modular reactor technology for synthesizing carbon-neutral fuels and chemicals from CO2 and H2O using renewable energy, promoting sustainability and industrial integration.
CFC Pilot for CCS
The CFCPILOT4CCS project aims to pilot Carbonate Fuel Cells for CO2 capture from industrial streams in Rotterdam, targeting 46,000 tonnes of greenhouse gas avoidance and enhancing technology for wider application.